Molecular Imaging and Therapeutics
The Division of Molecular Imaging and Therapeutics has three full-time clinical faculty members who perform all of the diagnostic and therapeutic nuclear medicine procedures. Additionally, two Cardiology faculty members interpret 50% of the cardiac imaging studies. Two physicists and two radiopharmacists are involved with clinical and research operations. We operate an in-house radiopharmacy.
The Division operates 2 SPECT/CT, 6 SPECT and 2 PET/CT cameras and has access to a PET/MR camera. The clinical operation expands over the UNC Medical Center and Hillsborough Hospital. The Division offers a very broad spectrum of nuclear medicine imaging procedures, including cardiac PET with Rubidium. Our extensive range of therapeutic procedures includes 131-I MIBG in pediatric neuroblastoma, 32-P in radiosynovectomy and polycythemia, Lutathera for metastatic neuroendocrine tumors, Xofigo for metastatic prostate cancer, 131-Iodine in benign and malignant thyroid conditions as well as 90-Y TheraSphere/ SIR-Spheres for radioembolization of liver tumors in cooperation with our Division of Vascular-Interventional Radiology. The Division performs approximately 12000 procedures each year, 5000 of which are PET studies, including about 1000 cardiac PET cases. We cover 8 multidisciplinary conferences where on dedicated workstation PET studies are reviewed.
Our faculty members are heavily involved in the training of diagnostic and interventional radiology residents as well as cardiology fellows and participate in RADY 401, the introductory radiology elective for medical students. The training program for the radiology residents includes lectures on NRC regulations, radiopharmacy and physics as well as hands-on training in the radiopharmacy and nuclear medicine camera and instrumentation, and related QC procedures. We also give clinical teaching conferences to residents and faculty members of other Departments and operate a Nuclear Medicine Technologists Training School.
The Molecular Imaging and Therapeutics faculty members are also involved in research and scholarship, and active members in national professional societies such as SNMMI, RSNA and ACR. The faculty has close collaborations with physicians and scientists across UNC School of Medicine and Lineberger Cancer Center, and been involved with many funded projects and clinical trials.
To make an appointment with Molecular Imaging and Therapeutics,
please call 984-974-1884.